Skip to main content

Table 1 Clinical and pathological findings of the patients affected by malignant melanoma

From: Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions

Patient n.

Age

Sex

Site

Thickness (mm)

S-LFN

LFN

Thickness ≤ 1 mm

      

1.

58

F

Groin

0.7

-

 

2.

34

F

Thigh

0.3

-

-

3.

41

M

Underscapular

0.88

-

 

4.

32

M

Costal

0.4

-

 

5.

50

M

Upperscapular

0.3

-

+

6.

34

F

Back

0.5

+ (itc)

-

7.

66

M

Lumbar

0.5

+ (itc)

-

8.

64

M

Paravertebral

0.5

-

 

9.

63

F

Leg

1

-

 

10.

70

M

Thorax

0.5

-

 

Thickness > 1 mm

      

1.

36

F

Thigh

1.2

-

 

2.

55

F

Knee

1.2

-

 

3.

31

M

Back

1.4

+ (itc)

-

4.

63

F

Forearm

1.1

-

 

5.

35

F

Thigh

2

+

-

6.

30

F

Thigh

1.7

-

 

7.

33

M

Arm

1.4

-

 

8.

62

F

Arm

3

-

 

9.

38

F

Pubis

2.7

+

-

10.

59

F

Leg

2

-

 
  1. S-LFN, sentinel lymph node; LFN, regional lymphadenectomy; itc, isolated tumour cells